Navigation Links
Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
Date:10/2/2007

Corrected Announcement Follows

NEW YORK, Oct. 2 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that I. Craig Henderson, MD, the Company's President, will present an overview of the Company's cancer pipeline at the upcoming William Blair & Company Small-Cap Growth Stock Conference in New York City. Dr. Henderson's presentation will take place on Wednesday, October 3rd at 12:00 noon ET.

Dr. Henderson's presentation will be webcast live and will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals, Inc. is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide), previously referred to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Sulonex is in a pivotal Phase III and Phase IV clinical program under a Special Protocol Assessment with the Food & Drug Administration. Additionally, Keryx is developing Zerenex(TM), an oral, iron- based compound that has the capacity to bind phosphate and form non-absorbable complexes. Zerenex is currently in Phase II clinical development for the treatment of hyperphosphatemia (elevated serum phosphorous levels) in patients with end-st
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Onchocerciasis: Presentation And Treatment
2. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
3. New lease of life for asthmatics by Accentia Biopharmaceuticals
4. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
5. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
6. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
7. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
8. Monogram Presents Results of First ETag Breast Cancer Studies
9. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
10. Recovering Pranab Mukherjee Likely to Be Discharged Tomorrow
11. Earth Day Celebrated With Hopes of a Greener Tomorrow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...UCCESS, N.Y., July 25 /PRNewswire-USNewswire/ -- A...ief Quality Officer and Vice President,of Strategi...alth Fund, a,national foundation committed to impr...ected the foundation,s Program on Health Care Qual...ww.newscom.com/cgi-bin/prnh/20080725/DC28791LOGO ...
(Date:7/25/2008)...ty of Phoenix employees at 62 campuses, 43 affilia...lp feed nation,s hungry, PHOENIX, July 25 /PRNews...n,s hungry as employees at University of Phoenix, ...artments and four subsidiaries collected,enough no...provide more,than 68,000 meals. The staggering tot...
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)... GA July 24, 2008 Being overweight or obese is n... but is also a public health issue that impacts ot... Health Services Research reveals that the extra ...eople could place a significant financial burden o...f dollars across the entire current Medicare popul...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Hunger Is Happening National Food Drive a Huge Success -- Donations Will Serve 68,000 Meals 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2
...de, a controversial non-steroidal anti-inflammator...ain the health ministry admitted that drug formula... and not evaluated for effectiveness are prescribe... Jurist, a group of lawyers in New Delhi had filed...
...had launched a new research project to prevent the...from attacking the people. The research will aim t...flect it from biting the human populations. Malari...nd is spread by the mosquitoes that bite an infect...
...f an adverse intrauterine environment could be an ...ular disease, according to the study published in ...gs was obtained by studying 13830 individuals born...ata pertaining to the primary causes of death betw...
...anced/metastatic breast cancer in postmenopausal w...sts as a second line of treatment for infertility ...ozole was used not on an experimental basis, but a...ovulation. However some feel that without clinica...
Other Medicine News:Health News:Justifying the use of letrozole for inducing ovulation 2
(Date:7/23/2008)... Work with Protein Therapeutics that Mod...AMBRIDGE, Mass., July 23 /- Taligen T...a corporate growth plan with the,appointment of Ab...d the,establishment of its headquarters in Cambrid...D., a co-founder of the company who remains presid...
(Date:7/22/2008)...s Development Initiative bring MJFF,s,current acti...nuary 20,2009, NEW YORK, July 22 /PRNewswire-USN...ry of transformative treatments and a cure for Par...r Parkinson,s Research has awarded,$2.7 million in... awards,were granted under MJFF,s Therapeutics Dev...
(Date:7/22/2008)... and Apidra(R) Resulted in Significant, Reductions... the Algorithm Us...sults from the "Adjust to,Target in Type 2 Diabete...e,Counting for Adjustment of Mealtime Insulin Glul...tes Association,s (ADA) medical journal,Diabetes ...
(Date:7/22/2008)...umbia University Medical Center Based on ..., The Test Differentiates Squamous From Non-Squa...ing Squamous-Cell Carcinoma of the Lung With ...Percent,This is the First CLIA Approved Test Which...arkers for Accurate Diagnosis of Lung Cancer, REH...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 1Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 2Pelosi Democrats Host Health Care Forum This Morning 9587 1Pelosi Democrats Host Health Care Forum This Morning 9587 2Pelosi Democrats Host Health Care Forum This Morning 9587 3Pelosi Democrats Host Health Care Forum This Morning 9587 4Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 1Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 1The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 3The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 4
...monstrates Utility in Evaluating Drug,Efficacy; Dr... HDL,Therapy , ,PLEASANTON, CA, Mar 30, 2007 (MARK..., Inc. (NASDAQ: LIPD) Dr. H. Bryan Brewer, Jr.,Ch...oncluded from,the wide range of presentations at t...ting in New Orleans that the rationale for HDL,bei...
...: Time to Pay Attention to this,Overlooked Disease...-- During,National Sexually Transmitted Disease (S...is urging increased awareness of, and,testing for,...common curable STD in the United States. Awareness...at trich affects an estimated 7.4,million men and ...
Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 2Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 3
Blunt tipped forceps with small, slightly pointed grasping platforms on each tip. For general purpose (fine) membrane grasping and grasping membranes adherent to the retlnal surface.
Wash both 96- and 384-well plates and strips with the ELx50 Auto Strip Washer. As a self contained and programmable instrument, the ELx50 allows for full control of precise fluidic delivery from the
...raocular Electromagnet offers a truly unique surgi...r foreign bodies (IOFB). Other magnets are availab...s an intraocular electromagnet for use through a p...The D.O.R.C. Intraocular Electromagnet offers the ...
Philips SureSigns C1 compact, portable monitor features non-invasive measurement of essential vital signs as well as versatile spot check and continuous monitoring capabilities. The C1, ideal for tra
Medicine Products: